Paul E. Wiedeman

3,5-Bis(trifluoromethyl)pyrazoles:  A Novel Class of NFAT Transcription Factor Regulator

Stevan W. Djurić, Nwe Y. BaMaung, Anwer Basha et al. · Journal of Medicinal Chemistry · 2000 · 120 citations

Molecular Regulation, Immunology, Pharmacotherapy +18

Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds

James M. Trevillyan, X. Grace Chiou, Yung‐Wu Chen et al. · Journal of Biological Chemistry · 2001 · 99 citations · Full text

Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes.

Paul E. Wiedeman, James M. Trevillyan · PubMed · 2003 · 64 citations

Glycobiology, Pharmacotherapy, Insulin Signaling +17

Discovery, Structure−Activity Relationship, and Pharmacological Evaluation of (5-Substituted-pyrrolidinyl-2-carbonyl)-2-cyanopyrrolidines as Potent Dipeptidyl Peptidase IV Inhibitors

Zhonghua Pei, Xiaofeng Li, Kenton L. Longenecker et al. · Journal of Medicinal Chemistry · 2006 · 61 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Biochemistry +14

The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class

Richard J. Sciotti, Marina Pliushchev, Paul E. Wiedeman et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 60 citations · Full text

Antifungal Agent, Bioorganic Chemistry, Novel Series +9